Asset Details
Do you wish to reserve the book?
RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes
Do you wish to request the book?
RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
RSV Prefusion F Protein–Based Maternal Vaccine — Preterm Birth and Other Outcomes
2024
Overview
An RSV prefusion F maternal vaccine was assessed for efficacy against RSV disease in infants. The trial was stopped early owing to a higher incidence of preterm birth in the vaccine group than in the placebo group.
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Age
/ Birth
/ Female
/ Humans
/ Infant
/ Infants
/ Neonates
/ Placebos
/ Premature Birth - chemically induced
/ Respiratory Syncytial Virus Infections - prevention & control
/ Respiratory Syncytial Virus Vaccines - administration & dosage
/ Respiratory Syncytial Virus Vaccines - adverse effects
/ Respiratory Syncytial Virus Vaccines - therapeutic use
/ Respiratory Syncytial Virus, Human
/ Respiratory Tract Diseases - prevention & control
/ Respiratory Tract Diseases - virology
/ Risk
/ Safety
/ Vaccines
